166 related articles for article (PubMed ID: 25385827)
1. Upregulation of ABC transporters contributes to chemoresistance of sphingosine 1-phosphate lyase-deficient fibroblasts.
Ihlefeld K; Vienken H; Claas RF; Blankenbach K; Rudowski A; ter Braak M; Koch A; Van Veldhoven PP; Pfeilschifter J; Meyer zu Heringdorf D
J Lipid Res; 2015 Jan; 56(1):60-9. PubMed ID: 25385827
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cholesterol homeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts reveals a Niemann-Pick disease type C-like phenotype with enhanced lysosomal Ca
Vienken H; Mabrouki N; Grabau K; Claas RF; Rudowski A; Schömel N; Pfeilschifter J; Lütjohann D; van Echten-Deckert G; Meyer Zu Heringdorf D
Sci Rep; 2017 Mar; 7():43575. PubMed ID: 28262793
[TBL] [Abstract][Full Text] [Related]
3. Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation.
Colié S; Van Veldhoven PP; Kedjouar B; Bedia C; Albinet V; Sorli SC; Garcia V; Djavaheri-Mergny M; Bauvy C; Codogno P; Levade T; Andrieu-Abadie N
Cancer Res; 2009 Dec; 69(24):9346-53. PubMed ID: 19934311
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a link between histone deacetylation and Ca²+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts.
Ihlefeld K; Claas RF; Koch A; Pfeilschifter JM; Meyer Zu Heringdorf D
Biochem J; 2012 Nov; 447(3):457-64. PubMed ID: 22908849
[TBL] [Abstract][Full Text] [Related]
5. S1P-lyase deficiency uncouples ganglioside formation - Potential contribution to tumorigenic capacity.
Hagen-Euteneuer N; Alam S; Rindsfuesser H; Meyer Zu Heringdorf D; van Echten-Deckert G
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158708. PubMed ID: 32283310
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Ca2+ storage in sphingosine-1-phosphate lyase-deficient fibroblasts.
Claas RF; ter Braak M; Hegen B; Hardel V; Angioni C; Schmidt H; Jakobs KH; Van Veldhoven PP; zu Heringdorf DM
Cell Signal; 2010 Mar; 22(3):476-83. PubMed ID: 19913094
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-phosphate-lyase deficiency affects glucose metabolism in a way that abets oncogenesis.
Afsar SY; Alam S; Fernandez Gonzalez C; van Echten-Deckert G
Mol Oncol; 2022 Oct; 16(20):3642-3653. PubMed ID: 35973936
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine 1-phosphate (S1P) lyase deficiency increases sphingolipid formation via recycling at the expense of de novo biosynthesis in neurons.
Hagen-Euteneuer N; Lütjohann D; Park H; Merrill AH; van Echten-Deckert G
J Biol Chem; 2012 Mar; 287(12):9128-36. PubMed ID: 22291021
[TBL] [Abstract][Full Text] [Related]
9. Gibberellin derivative GA-13315 sensitizes multidrug-resistant cancer cells by antagonizing ABCB1 while agonizes ABCC1.
Mo J; Kang M; Ye JX; Chen JB; Zhang HB; Qing C
Cancer Chemother Pharmacol; 2016 Jul; 78(1):51-61. PubMed ID: 27160689
[TBL] [Abstract][Full Text] [Related]
10. ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer.
Yamada A; Nagahashi M; Aoyagi T; Huang WC; Lima S; Hait NC; Maiti A; Kida K; Terracina KP; Miyazaki H; Ishikawa T; Endo I; Waters MR; Qi Q; Yan L; Milstien S; Spiegel S; Takabe K
Mol Cancer Res; 2018 Jun; 16(6):1059-1070. PubMed ID: 29523764
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine-1-phosphate lyase (SGPL1) deficiency is associated with mitochondrial dysfunction.
Maharaj A; Williams J; Bradshaw T; Güran T; Braslavsky D; Casas J; Chan LF; Metherell LA; Prasad R
J Steroid Biochem Mol Biol; 2020 Sep; 202():105730. PubMed ID: 32682944
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine phosphate lyase insufficiency syndrome (SPLIS): A novel inborn error of sphingolipid metabolism.
Choi YJ; Saba JD
Adv Biol Regul; 2019 Jan; 71():128-140. PubMed ID: 30274713
[TBL] [Abstract][Full Text] [Related]
13. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications.
Janecke AR; Xu R; Steichen-Gersdorf E; Waldegger S; Entenmann A; Giner T; Krainer I; Huber LA; Hess MW; Frishberg Y; Barash H; Tzur S; Schreyer-Shafir N; Sukenik-Halevy R; Zehavi T; Raas-Rothschild A; Mao C; Müller T
Hum Mutat; 2017 Apr; 38(4):365-372. PubMed ID: 28181337
[TBL] [Abstract][Full Text] [Related]
15. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin as a fluorescent reporter identifies novel MRP1 (ABCC1) inhibitors missed by calcein-based high content screening of anticancer agents.
Sampson A; Peterson BG; Tan KW; Iram SH
Biomed Pharmacother; 2019 Oct; 118():109289. PubMed ID: 31401398
[TBL] [Abstract][Full Text] [Related]
17. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
18. Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter.
Qiu JG; Zhang YJ; Li Y; Zhao JM; Zhang WJ; Jiang QW; Mei XL; Xue YQ; Qin WM; Yang Y; Zheng DW; Chen Y; Wei MN; Shi Z
Oncotarget; 2015 Jun; 6(17):15494-509. PubMed ID: 25915534
[TBL] [Abstract][Full Text] [Related]
19. Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis.
Billich A; Baumruker T; Beerli C; Bigaud M; Bruns C; Calzascia T; Isken A; Kinzel B; Loetscher E; Metzler B; Mueller M; Nuesslein-Hildesheim B; Kleylein-Sohn B
PLoS One; 2013; 8(3):e59630. PubMed ID: 23544080
[TBL] [Abstract][Full Text] [Related]
20. Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cells.
Issa ME; Hall SR; Dupuis SN; Graham CL; Jakeman DL; Goralski KB
Anticancer Drugs; 2014 Mar; 25(3):255-69. PubMed ID: 24231527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
